Scinai Immunotherapeutics (SCNI) Cash & Current Investments (2024 - 2025)
Scinai Immunotherapeutics (SCNI) has disclosed Cash & Current Investments for 2 consecutive years, with $1.8 million as the latest value for Q4 2025.
- Quarterly Cash & Current Investments fell 13.56% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, down 13.56% year-over-year, with the annual reading at $1.8 million for FY2025, 13.56% down from the prior year.
- Cash & Current Investments hit $1.8 million in Q4 2025 for Scinai Immunotherapeutics, down from $2.1 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $2.1 million in Q4 2024 to a low of $1.8 million in Q4 2025.